DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Navitoclax
Navitoclax
Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
2P2idb : Une Base De Données Dediée a La Druggabilité Des
Selective Targeting of Antiapoptotic BCL-2 Proteins in Cancer
Identifying the Druggable Interactome of EWS-FLI1 Reveals MCL-1 Dependent Differential Sensitivities of Ewing Sarcoma Cells to Apoptosis Inducers
A Method to Identify Physical, Chemical and Biological Factors That Trigger Bcl-Xl-Mediated Apoptosis
Rational Strategies for Combining Bcl-2 Inhibition with Targeted Drugs for Anti-Tumor Synergy
Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer
Exploiting MCL-1 Dependency with Combination MEK + MCL-1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS Mutant Non-Small Cell Lung Cancer
Dynamic BH3 Profiling Identifies Active BH3 Mimetic Combinations in Non-Small Cell Lung Cancer
Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS-Mutant Non–Small Cell Lung Cancer
Top View